This HTML5 document contains 152 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n10http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34519158
rdf:type
wikibase:Item
schema:description
wissenschaftlicher Artikel 2001年論文 мақолаи илмӣ บทความทางวิทยาศาสตร์ مقالهٔ علمی 2001年论文 tudományos cikk 2001年论文 articol științific tieteellinen artikkeli наукова стаття, опублікована в листопаді 2001 teaduslik artikkel επιστημονικό άρθρο مقالة علمية 2001年論文 научная статья 2001年论文 mokslinis straipsnis artículu científicu espublizáu en 2001 artigo científico 2001年の論文 article scientifique (publié 2001) 2001年论文 naučni članak artikull shkencor vedecký článok 2001년 논문 2001 թվականի նոյեմբերին հրատարակված գիտական հոդված научни чланак 2001年论文 article científic ২০০১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vitenskapelig artikkel bài báo khoa học artykuł naukowy vědecký článek bilimsel makale научни чланак мақолаи илмӣ 2001年論文 2001年論文 videnskabelig artikel (udgivet 2001) scienca artikolo scientific article 2001年论文 artículo científico publicado en 2001 2001 nî lūn-bûn articolo scientifico מאמר מדעי სამეცნიერო სტატია artigo científico (publicado na 2001) artikulong pang-agham article scientific vitskapeleg artikkel artigo científico (publicado na 2001) سائنسی مضمون 2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած vetenskaplig artikel научна статия 2001年論文 wetenschappelijk artikel
p:P577
wds:Q34519158-BAE40217-550E-42BA-9A82-B8FB4CE79684
wdt:P577
2001-11-01T00:00:00Z
p:P407
wds:Q34519158-ECCA37EB-F12F-4A5C-994C-A5C9AFC0A2D4
wdt:P407
wd:Q1860
p:P2093
wds:Q34519158-3FAD3370-30F3-46D5-94AF-88F0452BBF61 wds:Q34519158-601406F6-B1CB-4DC6-9635-1F64067C62A7 wds:Q34519158-4BFB7470-C9A8-4193-9132-A52439311FFB wds:Q34519158-4DF95960-9173-4DC2-A4DE-3512268C1CD5 wds:Q34519158-2098F7C9-CFA9-4800-BA5E-4D1F0982EDA5 wds:Q34519158-07F5F904-BC87-4F94-BF42-5893490A3A57 wds:Q34519158-300768BB-8E91-456A-B02D-FF3F12EE6436 wds:Q34519158-30098421-C010-4E95-A9A3-08B46392CC94 wds:Q34519158-2C92025F-729B-4955-8CE5-D2CE63906998 wds:Q34519158-D624D2E0-9950-442E-831F-C4075602FF68 wds:Q34519158-D8B05BB1-BA74-482B-945F-E000A7079D9B wds:Q34519158-FC62F0E0-B779-4419-9F35-8CA435D49A97 wds:Q34519158-F019EB0E-8777-4E98-B8D5-5C69FAFF5CAE wds:Q34519158-A00EA099-99F7-4CB6-997E-1A1AE79B42B1 wds:Q34519158-C33DEDA9-DE30-4E71-B09A-1F326C456DF0 wds:Q34519158-7B172D81-DAAE-4E2E-AA23-9B013C61D795 wds:Q34519158-60C5F156-DDF2-4809-92EF-515C82F88F89 wds:Q34519158-6609002D-45D3-4488-A5DF-33B28D5ADACB wds:Q34519158-906A72EE-7D17-491F-A5F2-85B29DF89481 wds:Q34519158-935A2DC9-005B-42FF-B296-19789E2C349B wds:Q34519158-84637078-0ABC-4FC5-9847-443C36613F43
wdt:P2093
J M Vieitez G Perez-Manga M Jahn P Thompson M Boyer D Allman M Findlay S Frings Xeloda Colorectal Cancer Study Group E Bajetta J Cassidy J F Seitz C Weitzel P Rougier E Van Cutsem R Rosso W H Schmiegel P Harper R Bugat J McKendrick B Osterwalder
rdfs:label
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study
skos:prefLabel
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study
schema:name
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study
p:P50
wds:Q34519158-9F7FA423-E0D9-4657-85E1-819DD77B1E1F
wdt:P50
wd:Q47067174
p:P1476
wds:Q34519158-B9E186C2-2809-4DDC-BD98-C2F44E63B033
wdt:P1476
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study
p:P304
wds:Q34519158-ECBF9FAD-D5D4-4652-AA60-CBB86B8D6DF0
wdt:P304
4097-4106
p:P31
wds:Q34519158-8AAB8EB1-1902-495D-B8F0-BBF647C4C832
wdt:P31
wd:Q13442814
p:P921
wds:Q34519158-A3E9903C-61FD-4D3D-92FC-CCAA5E4EF89E wds:Q34519158-C60B164F-346C-4F99-AD6C-4B4147B615EB wds:Q34519158-0CC38178-1A6B-4DF3-A098-EACD9FC42A59 wds:Q34519158-25F80D00-D10B-4DA0-BA0D-6B6A0548B840 wds:Q34519158-471EE903-2BF9-4902-AC0F-3D7410BC75D4 wds:Q34519158-499E79F3-FF80-4F01-BF09-ED6DDC25E6DC
wdt:P921
wd:Q420207 wd:Q238512 wd:Q181600 wd:Q108566365 wd:Q25493920 wd:Q188874
p:P698
wds:Q34519158-4153FA66-AC74-4B95-A489-7F7A6260E077
wdtn:P698
n12:11689577
wdt:P698
11689577
p:P1433
wds:Q34519158-5197906A-551B-4F5A-BA03-113F5A85EBE9
wdt:P1433
wd:Q400292
p:P433
wds:Q34519158-75F10822-495B-4361-A35F-2B4663FAD2C9
p:P478
wds:Q34519158-E54356C6-2576-4BC4-B8A2-D2DCA30F19E0
wdt:P433
21
wdt:P478
19
p:P356
wds:Q34519158-B51F4397-FE62-47D2-AAE5-C1E5CB1C6D5F
wdtn:P356
n10:JCO.2001.19.21.4097
wdt:P356
10.1200/JCO.2001.19.21.4097